Authors
Difery Minadzi, Augustine Yeboah, Millicent Lamptey, Monika M Vivekanandan, Joseph F Arthur, Hubert S Ahor, Wilfred Aniagyei, Samuel A Sakyi, Anthony A A Awuah, Rejoice A Arthur, Victoria A Ofori, Albert D Kegya, Linda A Amoakoa, Ernest Adankwah, Dorcas O Owusu, Ijeoma C Anyitey-Kokor, Mohammed K Abass, Fredrick G Apraku, Nana K Ayisi-Boateng, Seth Adane, Salisu Zakaria, Ertan Mayatepek, Julia Seyfarth, Richard O Phillips, Marc Jacobsen
Published in
Infection. Oct 19, 2026. Epub Oct 19, 2026.
Abstract
A considerable proportion of suspected pulmonary tuberculosis (pTB) cases are identified and treated on the basis of clinical diagnoses, as it is often not possible to confirm Mycobacterium tuberculosis (Mtb) infection. In the absence of pathogen detection, supplementary indicators, such as immunological biomarkers, would facilitate TB diagnostic decision-making.
In this prospective case-control study conducted in Ghana, patients with suspected pTB (n = 83) were divided into three subgroups: confirmed cases with high (pTBhigh) or low (pTBlow) Mtb sputum load, and clinically diagnosed patients without Mtb confirmation (pTBclin). pTB patient subgroups were then compared with healthy contacts (controls; n = 49) for their immune responses to Mtb antigens (i.e. PPDMtb, ESAT6/CFP10), the mitogen phytohemagglutinin, and a superantigen.
About half of the pTB patients were pTBclin (n = 41; 49.4%), while pTBhigh accounted for only about one-third (n = 26; 31.3%) and pTBlow for about one-fifth (n = 16; 19.3%). Antigen-specific CD4+ T-cell responses varied among the pTB subgroups, and only the pTBhigh group had higher IFNγ+/TNFα+ T-cell proportions as compared to controls (PPDMtb, p = 0.0003; ESAT6/CFP10, p < 0.0001). In contrast, phytohemagglutinin induced significantly lower proportions of CD4+ T cells in all TB subgroups (pTBhigh, p < 0.0001; pTBlow, p = 0.0039; pTBclin, p = 0.0012 for IFNγ+/TNFα+) and this measurement distinguished patient subgroups effectively from controls (pTBhigh, p < 0.0001; pTBlow, p = 0.0132; pTBclin, p = 0.0006 for TNFα+/CD40L+). Finally, TNFα+/CD40L+ T-cell responses to phytohemagglutinine had the highest efficiency to distinguish pTBclin with severe lung manifestation from controls (AUC = 0.9; p < 0.0001; 95%CI:0.82-0.98).
This study underscores the importance of clinical pTB diagnosis and identifies a reduced T-cell cytokine response to phytohemagglutinin as a potential biomarker.
PMID:
42895605
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 19
- Comments 0